Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Androgens and coronary artery disease.

Wu FC, von Eckardstein A.

Endocr Rev. 2003 Apr;24(2):183-217. Review.

PMID:
12700179
2.

Testosterone and atherosclerosis.

Eckardstein Av, Wu FC.

Growth Horm IGF Res. 2003 Aug;13 Suppl A:S72-84. Review.

PMID:
12914731
3.

Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?

LaRosa JC.

Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3.

PMID:
1617306
4.

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM.

Atherosclerosis. 2003 Jan;166(1):95-102.

PMID:
12482555
5.

Women, lipoproteins and cardiovascular disease risk.

LaRosa JC.

Can J Cardiol. 1990 May;6 Suppl B:23B-29B. Review.

PMID:
2188715
6.

Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness.

Adams MR, Williams JK, Kaplan JR.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):562-70.

7.

Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.

Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR.

Menopause. 2007 Jul-Aug;14(4):630-8.

PMID:
17224854
8.

[Cardiovascular risk factors and prevention in women: similarities and differences].

Sclavo M.

Ital Heart J Suppl. 2001 Feb;2(2):125-41. Review. Italian.

PMID:
11255880
9.

Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.

Ozata M, Yildirimkaya M, Bulur M, Yilmaz K, Bolu E, Corakci A, Gundogan MA.

J Clin Endocrinol Metab. 1996 Sep;81(9):3372-8.

PMID:
8784099
10.

Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome.

Christakou CD, Diamanti-Kandarakis E.

Womens Health (Lond Engl). 2008 Nov;4(6):583-94. doi: 10.2217/17455057.4.6.583. Review.

PMID:
19072461
11.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
12.
13.

The relationship between sex hormones and lipid profile in men with coronary artery disease.

Wranicz JK, Cygankiewicz I, Rosiak M, Kula P, Kula K, Zareba W.

Int J Cardiol. 2005 May 11;101(1):105-10.

PMID:
15860391
14.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

Metabolism. 1997 Nov;46(11):1287-93.

PMID:
9361687
15.

Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men.

Srinivasan M, Irving BA, Frye RL, O'Brien P, Hartman SJ, McConnell JP, Nair KS.

J Clin Endocrinol Metab. 2010 Apr;95(4):1617-25. doi: 10.1210/jc.2009-2000. Epub 2010 Feb 5.

16.

Inflammatory cardiovascular risk markers in women with hypopituitarism.

Sesmilo G, Miller KK, Hayden D, Klibanski A.

J Clin Endocrinol Metab. 2001 Dec;86(12):5774-81.

PMID:
11739438
17.

Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.

Erbel R, Lehmann N, Churzidse S, Möhlenkamp S, Moebus S, Mahabadi AA, Schmermund A, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bauer M, Bröcker-Preuss M, Mann K, Jöckel KH; Heinz Nixdorf Recall Study Investigators.

Atherosclerosis. 2013 Aug;229(2):531-40. doi: 10.1016/j.atherosclerosis.2013.04.015. Epub 2013 May 3.

PMID:
23701995
18.

Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

Dunajska K, Milewicz A, Jedrzejuk D, Szymczak J, Kuliczkowski W, Salomon P, Bialy D, Poczatek K, Nowicki P.

Endocrine. 2004 Dec;25(3):215-21.

PMID:
15758248
19.

Cholesterol, lipoproteins, and coronary heart disease in women.

Bush TL, Fried LP, Barrett-Connor E.

Clin Chem. 1988;34(8B):B60-70. Review.

PMID:
3042201
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk